XML 47 R27.htm IDEA: XBRL DOCUMENT v3.19.1
TAXES ON INCOME (Tables)
 12 Months Ended
Dec. 31, 2018
Income Tax Disclosure [Abstract]  
Schedule of Deferred Tax Assets
The components of the Company’s net deferred tax assets at December 31, 2017 and 2018 were as follows:
 
 
 
December 31,
 
(U.S. dollars in thousands)
 
2017
 
 
2018
 
In respect of:
 
 
 
 
 
 
 
 
Timing Differences of Protalix Ltd.
 
$
11,761
 
 
$
6,678
 
Timing Differences of Protalix BioTherapeutics, Inc.
 
 
(426
)
 
 
(501
)
Net operating loss carry forwards
 
 
47,033
 
 
 
49,436
 
Valuation allowance
 
 
(58,368
)
 
 
(55,613
)
 
 
 
-
 
 
 
-
 
Schedule of Open Tax Years
A summary of open tax years by major jurisdiction is presented below:
 
Jurisdiction:
 
Years:
Israel
 
2014
-
2018
United States (*)
 
2014
-
2018